A1RG34:BVMF
Argenx Se Bdr
R$222.17
0.00%
(0.00) 1D
ኖቬም 12, 3:02:53 ከሰዓት ጂ ኤም ቲ-3 · BRL
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for A1RG34...
Mkt. cap
60.49 ቢ
Avg. vol.
47.00
Volume
0.00
52-wk high
R$216.00
52-wk low
R$143.22
Shares outstanding
62.89 ሚ
No. of employees
2 ሺ
Mkt. cap
60.49 ቢ
Avg. vol.
47.00
Volume
0.00
52-wk high
R$216.00
52-wk low
R$143.22
Shares outstanding
62.89 ሚ
No. of employees
2 ሺ
News stories
From web sources and news partners
Trefis
·
ከ4 ሰዓቶች በፊት
S&P 500 Movers | Winners: CHTR, STE, GPN | Losers: AMD, DELL, CSCO
qz.com
·
ከ14 ሰዓቶች በፊት
How much of the S&P 500 is Nvidia? Concentration explained
Reuters
·
ከ22 ሰዓቶች በፊት
Goldman Sachs sees S&P 500 rising to 8,700 next year despite slower earnings growth
Traders Union
·
ከ21 ሰዓቶች በፊት
S&P 500 falls over 1% as selling pressure and cautious trading weigh ahead of inflation data
Profile
Argenx SE is a Belgian-Dutch pharmaceutical company specializing in immunology. Argenx specializes in the development of antibody therapies for the treatment of autoimmune diseases and cancer. Its work primarily focuses on the development of orphan drugs. Wikipedia
About Argenx Se Bdr
CEO-
Employees1.86 ሺ
Founded25 ኤፕሪ 2008
Headquarters-
SectorHealth Care
IndustryBiotechnology
Websiteargenx.com